Stripe, Anthropic, and OpenAI Are Backing Effort To Stop Respiratory Infections

An anonymous reader quotes a report from MIT Technology Review: [T]he payment company Stripe, founded by brothers Patrick and John Collison, says it will fund a new $500 million nonprofit whose goal is preventing both the common cold and the flu. Its eventual aim is to get rid of respiratory viruses altogether. The new organization, called Intercept, will use grants and investments to back prevention approaches, including vaccines, as well as large-scale air-cleaning systems for schools, offices, and other public spaces. In addition to Stripe, other funders include Anthropic, Flu Lab, and the OpenAI Foundation, as well as Bill Gates and several traders at the quantitative investing fund Jane Street Capital, according to an Intercept spokesperson. "I think we treat respiratory infections as a minor nuisance, but have really underweighted the burden that they impose on society," says Nan Ransohoff, the Stripe executive leading the initiative along with Charlie Petty, a venture capitalist who joined Stripe this year. On average, people spend 5% of their lifetime fighting a cold or the flu, according to Ransohoff. Despite that, drug companies put relatively little effort into preventing colds. Part of the problem is that the sniffles are caused by more than 200 different viruses, according to the American Lung Association, with rhinoviruses being the most common culprits. There are so many that it typically doesn't pay to try to stop any one of them with a vaccine. "When pharma companies look at it, it's not as attractive as other things they could work on," says Ransohoff. "So it hasn't attracted the resources." [...] The project takes inspiration from efforts to fight the covid-19 virus, where Veesler's group was among those involved in the speedy development of vaccines, antiviral drugs, and antibodies. According to Ransohoff, Intercept's advisors will include Peter Marks, a former top FDA official, as well as Moncef Slaoui, the pharmaceutical executive who led the US coronavirus vaccine effort, Operation Warp Speed. A key challenge for Intercept will be coming up with ways to counter many viruses at one time. That accounts for the interest in air-cleaning technology, such as using strong ultraviolet light to inactivate viruses. The idea, the group says, is to remove them from the air in the same way municipalities remove impurities from the water supply before it's piped to people's homes.